CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Clinical trial NCT07057349 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07057349
Sponsor: Cytosite Biopharma Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer Unresectable Solid Tumor

Start date: 2025-09-01
Primary completion: 2027-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.